Nanobiotix Joins Euronext Tech Leaders Segment: Enhanced Visibility Among International Investors
French biotech company Nanobiotix announced on Tuesday its inclusion in the Euronext Tech Leaders segment and the corresponding index, an initiative launched by Euronext in 2022 to promote innovative and growing technology companies to international investors.
Recognition of Leadership in Physical and Nanotechnology Innovation
This inclusion reflects Nanobiotix's positioning at the intersection of nanotechnology, physics, and medicine, as the company develops a portfolio of nano-therapeutic platforms based on physics, aimed at addressing significant unmet medical needs. Laurent Levy, CEO and Chairman of the Executive Board of Nanobiotix, stated that this recognition underscores the progress made by the company and the broader potential of physics-based innovation to significantly contribute to the future of healthcare.
Benefits of Membership in the Euronext Program
Members of the Euronext Tech Leaders segment enjoy increased visibility among international investors, access to a broad network of market participants, and participation in events and initiatives designed to support long-term growth. Based in Paris and listed on Euronext since 2012, Nanobiotix also has a subsidiary in Cambridge, Massachusetts, and has been listed on the Nasdaq since December 2020.
